Hemogenyx Pharmaceuticals Plc (LON: HEMO)
London
· Delayed Price · Currency is GBP · Price in GBX
358.50
+15.10 (4.40%)
Dec 23, 2024, 4:35 PM BST
Hemogenyx Pharmaceuticals Market Cap
Hemogenyx Pharmaceuticals has a market cap or net worth of 12.03 million as of December 23, 2024. Its market cap has decreased by -52.93% in one year.
Market Cap
12.03M
Enterprise Value
13.14M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
358.50
Market Cap Chart
Since October 6, 2017, Hemogenyx Pharmaceuticals's market cap has increased from 10.68M to 12.03M, an increase of 12.67%. That is a compound annual growth rate of 1.67%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca PLC | 159.00B |
GSK plc | 53.86B |
Haleon plc | 34.50B |
Smith & Nephew plc | 8.48B |
ConvaTec Group PLC | 4.52B |
Hikma Pharmaceuticals PLC | 4.33B |
Oxford Nanopore Technologies plc | 1.37B |
Animalcare Group plc | 143.09M |